merck's hcv drug bring's in only $21 million, page-6

The trial and ultimately the results have been delayed so many times this year its hard for the market to get excited. When the trial results do finally come out, hopefully in a few weeks, then there will be action a-plenty.

I agree that it has held very quite well given the general selloff of any perceived risk. This one its without risk but the potential rewards are huge and I'd suggest the limited trading and stable price indicate that most holders have waited long enough, and they aren't going to panic for the sake of a couple of extra weeks.

The above said, somebody please panic, my buy order isn't going to get filled the way things are going.